Actively Recruiting
Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment
Led by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Updated on 2025-08-12
400
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective observational cohort study (AI-Kidney-Prognosis), aiming to non-invasively predict the clinical outcomes in renal cell carcinoma patients after surgical treatment using radiomics-based AI models, thereby assisting clinical decision-making and personalized follow-up strategies.
CONDITIONS
Official Title
Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients treated for renal cell carcinoma at Wuhan Union Hospital from August 2025 to August 2026
- Age greater than 18 years old
- At least one abdominal CT scan before treatment
- Diagnosis of renal cell carcinoma confirmed by tissue biopsy pathological examination
You will not qualify if you...
- Poor quality of imaging
- Incomplete clinical data or loss of follow-up
- Presence of another primary malignancy besides renal cell carcinoma
- Unclear pathological diagnosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Union Hospital，Tongji Medical College，Huazhong University of Science and Technology
Wuhan, Hubei, China, 430000
Actively Recruiting
Research Team
L
Lian Yang
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here